Global epidemic pneumonia in 2020 has brought a new dawn to bioscience and health care industries around the world. Therefore, EU has launched the largest subsidy program to support bioscience and medical technology, but apart from funding, a global approach is a key factor for future success. The integration of expertise in leading health and safety standards in China and Europe is a guarantee for future success in the Chinese local market and on a global scale.
Dexin helps support Chinese technology companies to establish business bases in Europe through cooperation and joint ventures. DEXIN will further support merger and acquisition methods from bioscience manufacturing to healthcare technology, enhance technology and brand advantages, generate market cooperative effect, and promote local business growth!